BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22951975)

  • 21. Canonical and alternate functions of the microRNA biogenesis machinery.
    Chong MM; Zhang G; Cheloufi S; Neubert TA; Hannon GJ; Littman DR
    Genes Dev; 2010 Sep; 24(17):1951-60. PubMed ID: 20713509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-16 suppresses metastasis in an orthotopic, but not autochthonous, mouse model of soft tissue sarcoma.
    Sachdeva M; Whitley MJ; Mito JK; Ma Y; Lev DC; Cardona DM; Kirsch DG
    Dis Model Mech; 2015 Aug; 8(8):867-75. PubMed ID: 26044957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DICER-dependent biogenesis of let-7 miRNAs affects human cell response to DNA damage via targeting p21/p27.
    Liu B; Liu M; Wang J; Zhang X; Wang X; Wang P; Wang H; Li W; Wang Y
    Nucleic Acids Res; 2015 Feb; 43(3):1626-36. PubMed ID: 25578966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion.
    Jafarnejad SM; Ardekani GS; Ghaffari M; Martinka M; Li G
    Oncogene; 2013 Apr; 32(17):2131-9. PubMed ID: 22689055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A precursor microRNA in a cancer cell nucleus: get me out of here!
    Melo SA; Esteller M
    Cell Cycle; 2011 Mar; 10(6):922-5. PubMed ID: 21346411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DICER1 screening in 15 paediatric paratesticular sarcomas unveils an unusual DICER1-associated sarcoma.
    Apellaniz-Ruiz M; Cullinan N; Grant R; Marrano P; Priest JR; Thorner PS; Goudie C; Foulkes WD
    J Pathol Clin Res; 2020 Jul; 6(3):185-194. PubMed ID: 32222066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dicer expression and microRNA dysregulation associate with aggressive features in thyroid cancer.
    Erler P; Keutgen XM; Crowley MJ; Zetoune T; Kundel A; Kleiman D; Beninato T; Scognamiglio T; Elemento O; Zarnegar R; Fahey TJ
    Surgery; 2014 Dec; 156(6):1342-50; discussion 1350. PubMed ID: 25456905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.
    Anglesio MS; Wang Y; Yang W; Senz J; Wan A; Heravi-Moussavi A; Salamanca C; Maines-Bandiera S; Huntsman DG; Morin GB
    J Pathol; 2013 Feb; 229(3):400-9. PubMed ID: 23132766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
    Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
    J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variant Analysis of miRNA Regulatory Genes in 35 Sporadic Lung Carcinoma Tumors.
    Bağcı Ö; Özdemir EM; Şanlıtürk B
    Dokl Biochem Biophys; 2023 Dec; 513(Suppl 1):S1-S7. PubMed ID: 38472669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs.
    Su X; Chakravarti D; Cho MS; Liu L; Gi YJ; Lin YL; Leung ML; El-Naggar A; Creighton CJ; Suraokar MB; Wistuba I; Flores ER
    Nature; 2010 Oct; 467(7318):986-90. PubMed ID: 20962848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired micro-RNA pathways diminish osteoclast differentiation and function.
    Sugatani T; Hruska KA
    J Biol Chem; 2009 Feb; 284(7):4667-78. PubMed ID: 19059913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired expression of DICER and some microRNAs in HBZ expressing cells from acute adult T-cell leukemia patients.
    Gazon H; Belrose G; Terol M; Meniane JC; Mesnard JM; Césaire R; Peloponese JM
    Oncotarget; 2016 May; 7(21):30258-75. PubMed ID: 26849145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
    Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
    Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dicer recognizes the 5' end of RNA for efficient and accurate processing.
    Park JE; Heo I; Tian Y; Simanshu DK; Chang H; Jee D; Patel DJ; Kim VN
    Nature; 2011 Jul; 475(7355):201-5. PubMed ID: 21753850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Centenarians maintain miRNA biogenesis pathway while it is impaired in octogenarians.
    Borrás C; Serna E; Gambini J; Inglés M; Vina J
    Mech Ageing Dev; 2017 Dec; 168():54-57. PubMed ID: 28754532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF.
    Cisowski J; Sayin VI; Liu M; Karlsson C; Bergo MO
    Oncogene; 2016 Mar; 35(10):1328-33. PubMed ID: 26028035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sarcomas of the central nervous systems. Clinical observations].
    Ryzhova MV; Galstyan SA; Telysheva EN; Shaikhaev EG; Snigireva GP; Gorelyshev SK; Kadyrov SU; Shimanskiy VN; Shugay SV; Panina TN
    Arkh Patol; 2022; 84(3):40-47. PubMed ID: 35639842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations.
    Tissot C; Couraud S; Tanguy R; Bringuier PP; Girard N; Souquet PJ
    Lung Cancer; 2016 Jan; 91():23-8. PubMed ID: 26711930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.
    Qi Y; Wang D; Huang W; Wang B; Huang D; Xiong F; Chen X; Chen Y
    J Exp Clin Cancer Res; 2019 Oct; 38(1):413. PubMed ID: 31590696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.